治疗前血糖和纤维蛋白原水平是潜在风险因子，纤维蛋白原的持续升高提示预后较差。
High blood sugar and fibrinogen levels may be potential risk factors, in particular, a high fibrinogen level implies a poor prognosis.
两组于治疗前、后分别采静脉血检测血浆纤维蛋白原、红细胞压积、全血粘度和血浆粘度的变化。
Venous blood samples were taken respectively in the two groups to detect the changes of plasma fibrinogen, hematocrit, whole blood viscosity and plasma viscosity.
结果输注代血浆和平衡液后全血粘度、血浆粘度、HCT、红细胞聚集指数、纤维蛋白原两组均较输注前明显降低（P<0.05），但两组间比较无显著差异（P>0.05）。
Results Blood viscosity, HCT, index of RBC aggregation and fibrinogen decreased significantly(P<0.05)in each group and there was no significant difference between the two groups(P>0.05).
应用推荐